200 related articles for article (PubMed ID: 35759198)
21. Pyrin-associated autoinflammation with neutrophilic dermatosis related to heterozygous MEFV gene variants in cis: Two case reports in a family.
Wu N; Li F; Wu D; Zheng W; Shen M
Gene; 2024 Apr; 901():148155. PubMed ID: 38211898
[No Abstract] [Full Text] [Related]
22. Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activation.
Masters SL; Lagou V; Jéru I; Baker PJ; Van Eyck L; Parry DA; Lawless D; De Nardo D; Garcia-Perez JE; Dagley LF; Holley CL; Dooley J; Moghaddas F; Pasciuto E; Jeandel PY; Sciot R; Lyras D; Webb AI; Nicholson SE; De Somer L; van Nieuwenhove E; Ruuth-Praz J; Copin B; Cochet E; Medlej-Hashim M; Megarbane A; Schroder K; Savic S; Goris A; Amselem S; Wouters C; Liston A
Sci Transl Med; 2016 Mar; 8(332):332ra45. PubMed ID: 27030597
[TBL] [Abstract][Full Text] [Related]
23. The possession of exon 2 or exon 3 variants in the MEFV gene promotes inflammasome activation in Japanese patients with familial Mediterranean fever with a heterozygous exon 10 mutation.
Endo Y; Koga T; Hara K; Furukawa K; Agematsu K; Yachie A; Masumoto J; Migita K; Kawakami A
Clin Exp Rheumatol; 2020; 38 Suppl 127(5):49-52. PubMed ID: 33331265
[TBL] [Abstract][Full Text] [Related]
24. Familial Mediterranean fever mutations lift the obligatory requirement for microtubules in Pyrin inflammasome activation.
Van Gorp H; Saavedra PH; de Vasconcelos NM; Van Opdenbosch N; Vande Walle L; Matusiak M; Prencipe G; Insalaco A; Van Hauwermeiren F; Demon D; Bogaert DJ; Dullaers M; De Baere E; Hochepied T; Dehoorne J; Vermaelen KY; Haerynck F; De Benedetti F; Lamkanfi M
Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14384-14389. PubMed ID: 27911804
[TBL] [Abstract][Full Text] [Related]
25. [Role of genetics in familial Mediterranean fever].
Kallinich T; Orak B; Wittkowski H
Z Rheumatol; 2017 May; 76(4):303-312. PubMed ID: 28154935
[TBL] [Abstract][Full Text] [Related]
26. Genetic and clinical features of familial mediterranean fever (FMF) in a homogeneous cohort of patients from South-Eastern Italy.
Di Ciaula A; Iacoviello M; Bonfrate L; Khalil M; Shanmugam H; Lopalco G; Bagnulo R; Garganese A; Iannone F; Resta N; Portincasa P; Stella A
Eur J Intern Med; 2023 Sep; 115():79-87. PubMed ID: 37183082
[TBL] [Abstract][Full Text] [Related]
27. Gene-Dose Effect of
Stoler I; Freytag J; Orak B; Unterwalder N; Henning S; Heim K; von Bernuth H; Krüger R; Winkler S; Eschenhagen P; Seipelt E; Mall MA; Foell D; Kessel C; Wittkowski H; Kallinich T
Front Immunol; 2020; 11():716. PubMed ID: 32655537
[TBL] [Abstract][Full Text] [Related]
28. Genome-wide association study in Turkish and Iranian populations identify rare familial Mediterranean fever gene (MEFV) polymorphisms associated with ankylosing spondylitis.
Li Z; Akar S; Yarkan H; Lee SK; Çetin P; Can G; Kenar G; Çapa F; Pamuk ON; Pehlivan Y; Cremin K; De Guzman E; Harris J; Wheeler L; Jamshidi A; Vojdanian M; Farhadi E; Ahmadzadeh N; Yüce Z; Dalkılıç E; Solmaz D; Akın B; Dönmez S; Sarı İ; Leo PJ; Kenna TJ; Önen F; Mahmoudi M; Brown MA; Akkoc N
PLoS Genet; 2019 Apr; 15(4):e1008038. PubMed ID: 30946743
[TBL] [Abstract][Full Text] [Related]
29. Experimental models in Familial Mediterranean Fever (FMF): Insights into pathophysiology and therapeutic strategies.
Mezher N; Mroweh O; Karam L; Ibrahim JN; Kobeissy PH
Exp Mol Pathol; 2024 Feb; 135():104883. PubMed ID: 38266955
[TBL] [Abstract][Full Text] [Related]
30. Familial Mediterranean fever patients homozygous for E148Q variant may have milder disease.
Topaloglu R; Batu ED; Yıldız Ç; Korkmaz E; Özen S; Beşbaş N; Özaltın F
Int J Rheum Dis; 2018 Oct; 21(10):1857-1862. PubMed ID: 27457448
[TBL] [Abstract][Full Text] [Related]
31. Improvement of MEFV gene variants classification to aid treatment decision making in familial Mediterranean fever.
Accetturo M; D'Uggento AM; Portincasa P; Stella A
Rheumatology (Oxford); 2020 Apr; 59(4):754-761. PubMed ID: 31411330
[TBL] [Abstract][Full Text] [Related]
32. Behçet disease, familial Mediterranean fever and MEFV variations: More than just an association.
Seyahi E; Ugurlu S; Amikishiyev S; Gul A
Clin Immunol; 2023 Jun; 251():109630. PubMed ID: 37216220
[TBL] [Abstract][Full Text] [Related]
33. The Pyrin Inflammasome in Health and Disease.
Schnappauf O; Chae JJ; Kastner DL; Aksentijevich I
Front Immunol; 2019; 10():1745. PubMed ID: 31456795
[TBL] [Abstract][Full Text] [Related]
34. One novel and two uncommon MEFV mutations in Japanese patients with familial Mediterranean fever: a clinicogenetic study.
Kishida D; Yazaki M; Nakamura A; Nomura F; Kondo T; Uehara T; Ikusaka M; Ohya A; Watanabe N; Endo R; Kawaai S; Shimojima Y; Sekijima Y
Rheumatol Int; 2018 Jan; 38(1):105-110. PubMed ID: 29151129
[TBL] [Abstract][Full Text] [Related]
35. Complex regulation of alarmins S100A8/A9 and secretion via gasdermin D pores exacerbates autoinflammation in familial Mediterranean fever.
Jorch SK; McNally A; Berger P; Wolf J; Kaiser K; Chetrusca Covash A; Robeck S; Pastau I; Fehler O; Jauch-Speer SL; Hermann S; Schäfers M; Van Gorp H; Kanneganti A; Dehoorne J; Haerynck F; Penco F; Gattorno M; Chae JJ; Kubes P; Lamkanfi M; Wullaert A; Sperandio M; Vogl T; Roth J; Austermann J
J Allergy Clin Immunol; 2023 Jul; 152(1):230-243. PubMed ID: 36822481
[TBL] [Abstract][Full Text] [Related]
36. GSDMD is critical for autoinflammatory pathology in a mouse model of Familial Mediterranean Fever.
Kanneganti A; Malireddi RKS; Saavedra PHV; Vande Walle L; Van Gorp H; Kambara H; Tillman H; Vogel P; Luo HR; Xavier RJ; Chi H; Lamkanfi M
J Exp Med; 2018 Jun; 215(6):1519-1529. PubMed ID: 29793924
[TBL] [Abstract][Full Text] [Related]
37. Two Cases of Familial Mediterranean Fever Involving MEFV Variants: The Importance of Differentiating the Diagnosis from COVID-19.
Nakayama T; Kozu Y
Intern Med; 2023 Feb; 62(4):643-647. PubMed ID: 36450463
[TBL] [Abstract][Full Text] [Related]
38. Defect of suppression of inflammasome-independent interleukin-8 secretion from SW982 synovial sarcoma cells by familial Mediterranean fever-derived pyrin mutations.
Sugiyama R; Agematsu K; Migita K; Nakayama J; Mokuda S; Ogura F; Haraikawa K; Okumura C; Suehiro S; Morikawa S; Ito Y; Masumoto J
Mol Biol Rep; 2014 Jan; 41(1):545-53. PubMed ID: 24318677
[TBL] [Abstract][Full Text] [Related]
39. The NLRP3 and Pyrin Inflammasomes: Implications in the Pathophysiology of Autoinflammatory Diseases.
de Torre-Minguela C; Mesa Del Castillo P; Pelegrín P
Front Immunol; 2017; 8():43. PubMed ID: 28191008
[TBL] [Abstract][Full Text] [Related]
40. The pyrin inflammasome, a leading actor in pediatric autoinflammatory diseases.
La Bella S; Di Ludovico A; Di Donato G; Basaran O; Ozen S; Gattorno M; Chiarelli F; Breda L
Front Immunol; 2023; 14():1341680. PubMed ID: 38250061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
